eTable 2. Assessment of the methodological quality of the meta-analyses of controlled trials of medical hypnosis by means of AMSTAR (8).
Reference | Was an ’a priori’ design provided?* | Was there duplicate study selection and data extraction? | Was a comprehensive literature search performed? | Was the status of publication _(i.e. grey literature) used as an inclusion criterion? | Was a list of studies (included and excluded) provided? | Were the characteristics of the included studies provided? | Was the scientific quality of the included studies assessed and documented? | Was the scientific quality of the included studies used appropriately in formulating conclusions? | Were the methods used to combine the findings of studies appropriate? | Was the likelihood of publication bias assessed? | Was the conflict of interest included? | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kekecs et al. 2014 (10) |
No | No | Yes | No | No | Yes | Yes | Yes | Yes | Yes | No | 6 |
Madden et al. 2012 (11) |
Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | 10 |
Schäfert et al. 2014 (12) |
No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | No | 8 |
Schnur et al. 2008 (13) |
No | Yes | No | No | No | Yes | No | No | Yes | Yes | No | 4 |
Tefikow et al. 2013 (14) |
Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | No | 8 |
*a priori design: protocol. internal review board approval. or research question previously published?
AMSTAR. A Measurement Tool to Assess Systematic Reviews